AVEO PHARMACEUTICALS INC's ticker is AVEO and the CUSIP is 053588109. A total of 55 filers reported holding AVEO PHARMACEUTICALS INC in Q3 2014. The put-call ratio across all filers is 27.25 and the average weighting 1.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2018 | $75,000 | +17.2% | 25,809 | +12.5% | 0.00% | – |
| Q4 2017 | $64,000 | -14.7% | 22,944 | +11.2% | 0.00% | – |
| Q3 2017 | $75,000 | +63.0% | 20,642 | +0.7% | 0.00% | – |
| Q2 2017 | $46,000 | +283.3% | 20,502 | 0.0% | 0.00% | – |
| Q1 2017 | $12,000 | +20.0% | 20,502 | +11.1% | 0.00% | – |
| Q4 2016 | $10,000 | -37.5% | 18,454 | 0.0% | 0.00% | – |
| Q3 2016 | $16,000 | -11.1% | 18,454 | -0.7% | 0.00% | – |
| Q2 2016 | $18,000 | +5.9% | 18,592 | 0.0% | 0.00% | – |
| Q1 2016 | $17,000 | 0.0% | 18,592 | +40.4% | 0.00% | – |
| Q4 2015 | $17,000 | +6.2% | 13,239 | 0.0% | 0.00% | – |
| Q3 2015 | $16,000 | -20.0% | 13,239 | +14.3% | 0.00% | – |
| Q2 2015 | $20,000 | +17.6% | 11,586 | 0.0% | 0.00% | – |
| Q1 2015 | $17,000 | +88.9% | 11,586 | +14.3% | 0.00% | – |
| Q4 2014 | $9,000 | -78.6% | 10,139 | -55.9% | 0.00% | – |
| Q2 2014 | $42,000 | -14.3% | 22,975 | -30.1% | 0.00% | – |
| Q1 2014 | $49,000 | +133.3% | 32,890 | +193.4% | 0.00% | – |
| Q4 2013 | $21,000 | – | 11,210 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| NEA Management Company, LLC | 25,243,865 | $16,913,000 | 1.18% |
| SABBY MANAGEMENT, LLC | 281,112 | $189,000 | 0.24% |
| New Leaf Venture Partners, L.L.C. | 402,118 | $271,000 | 0.07% |
| WealthTrust Axiom LLC | 134,585 | $90,000 | 0.03% |
| EXCALIBUR MANAGEMENT CORP | 51,000 | $34,000 | 0.03% |
| Caption Management, LLC | 748,200 | $503,000 | 0.02% |
| Anson Funds Management LP | 98,986 | $66,000 | 0.02% |
| GSA CAPITAL PARTNERS LLP | 210,474 | $142,000 | 0.02% |
| Evercore Wealth Management, LLC | 418,414 | $282,000 | 0.01% |
| Gemmer Asset Management LLC | 1,939 | $31,000 | 0.01% |